CONMED Corporation vs. Nexalin Technology, Inc. Common Stock
Nexalin Technology, Inc. Common Stock (NXL) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| CNMD | NXL | |
|---|---|---|
| Market Cap | $1.38 billion | $6.26 million |
| Revenue (TTM) | — | $217,155 |
| Net Income (TTM) | — | $-8,988,864 |
CNMD leads on 1 of 1 size & scale factors.
Valuation
| CNMD | NXL | |
|---|---|---|
| Price / Book | — | 4.12 |
| Price / Sales | — | 28.84 |
CNMD and NXL split the valuation factors evenly.
Profitability
| CNMD | NXL | |
|---|---|---|
| Net Margin | — | -4139.38% |
| Return on Equity | — | -591.60% |
CNMD and NXL split the profitability factors evenly.
Dividend
| CNMD | NXL | |
|---|---|---|
| Dividend Yield | 1.73% | 21.82% |
NXL leads on 1 of 1 dividend factors.
Risk & Sentiment
| CNMD | NXL | |
|---|---|---|
| Short Interest | 2.50% | 2.34% |
NXL leads on 1 of 1 risk & sentiment factors.
Dig deeper: CNMD overview, CNMD financials, NXL overview, NXL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.